Using AHR precision diagnostics we will become a leading provider to improve response to cancer immunotherapy by 2026
We extensively profiled multiple activators of the AHR and the subsequent transcriptional responses across multiple tissues and cancers.
Our bioinformatics platform analyses high throughput data for AHR activation and functions from gene expression, proteome and metabolome data.LEARN MORE
AHR SIGNATURE DATABASE
We possess a broad database of AHR signatures. This database enables us to investigate AHR activity in cancer and autoimmune diseases.LEARN MORE
We perform studies for biomarker verification, validation and CDx development in AHR-related therapeutic development programs .LEARN MORE
Our business model
Contact us for more information